All Perspectives
9567 total results. Page 3 of 383.
On March 4, 2025, the US Court of Appeals for the Second Circuit in Estate of Kalikow v. Comm’r., 135 AFTR 2d 2025-831 (2d Cir. 2025), upheld the US Tax Court’s prior ruling in Estate of Kalikow v. Comm’r., T.C. Memo. 2023-21, and affirmed that a settlement resolving an undistributed income claim against a Qualified Terminable Interest Property (QTIP) trust in favor of the decedent’s estate did not reduce the value of the assets included in the estate.
The US Food and Drug Administration (FDA) has now escalated its Drug Supply Chain Security Act (DSCSA) findings at Pure Indulgence Aesthetics from a Form FDA 483 (given to the company at the close of a December 2025 inspection) to a formal Warning Letter, issued on April 1.
While Section 232 tariffs have so far been largely a metals-and-autos story, pharma has now officially joined the narrative.
A recent federal court decision is a helpful reminder for any company whose products carry a “Made in the USA” label — or anything close to it.
International Trade & Investment Co-Leader and Partner Nancy Noonan will provide insights on emerging issues and recent developments in customs and trade at The University of Illinois Chicago School of Law’s 24th Annual Dominick L. DiCarlo US Court of International Trade Lecture on April 9, 2026.
Last week, a unanimous Seventh Circuit panel concluded that the Illinois General Assembly’s recent change to the calculation of statutory damages under Illinois’ Biometric Information Privacy Act (BIPA) applies retroactively to cases that were filed before the legislature’s amendment took effect. The decision significantly reduces exposure for companies facing BIPA cases.
On March 26, President Trump signed a new executive order (EO) imposing mandatory anti-diversity, equity, and inclusion (DEI) clauses in all federal contracts and subcontracts, with key compliance deadlines beginning as early as April 25.
Partner James Kim was quoted on the various strategies companies are enacting to address receiving tariff refunds.
On March 31, the American College of Investment Counsel (ACIC) released comprehensive updates to all four Model Form Note Purchase Agreements used in domestic and cross-border private placement transactions.
On April 1, the Financial Crimes Enforcement Network (FinCEN) submitted a Notice of Proposed Rulemaking proposing regulations to establish a formal Whistleblower Program under 31 U.S.C. § 5323.
Chicago Partner Matthew Prewitt will participate in the 8th Annual Trade Secrets, Noncompetes, and Other Competitive Restrictions — Hot Topics and Latest Developments program on April 7 in Chicago.
Automotive & Transportation Group Chair Aaron Jacoby was featured by Daily Journal on the wave of legal and regulatory conflict stemming from electric vehicle (EV) manufacturers’ trend toward direct-to-consumer sales, a move that is rocking the automotive industry.
Prop 65 Counsel: What To Know
Headlines that Matter for Companies and Executives in Regulated Industries
On April 2, President Trump signed a new Proclamation titled “Strengthening Actions Taken to Adjust Imports of Aluminum, Steel, and Copper Into the United States,” which fundamentally restructures how Section 232 tariffs are assessed on steel, aluminum, copper, and their derivative products.
The Federal Trade Commission’s (FTC) recent case against OkCupid and Match Group Americas is a classic FTC Section 5 deception action focused on false and misleading privacy promises about third-party data sharing, with the notable distinction that the third-party recipient was an artificial intelligence (AI) company.
ArentFox Schiff’s Pat Naples discusses with Medical Economics the US Centers for Medicare & Medicaid Services’ (CMS) expanded anti‑fraud enforcement and its impact on health care providers.
Michelle J. Shapiro to speak at Executive Women in Bio (EWIB) virtual program – Implementing Lessons Learned From Enforcement Developments to Improve Corporate Compliance.
AFS Senior Counsel Richard Liskov and Senior Associate Anna Mandel will speak on a CLE-accredited webinar hosted by Wickard AI, a specialized education and advisory firm operating at the intersection of law, artificial intelligence, ethics, and public policy.
Historically, menopause has not been specifically identified as a protected medical condition under state and federal law, even though its related symptoms in many cases are medical conditions covered by existing leave and accommodation laws. That is rapidly changing.
As many FBA members know by now, the FBA realized a significant and longstanding objective in December of 2025 with the enactment of the Foundation
of the Federal Bar Charter Amendments Act.
Partner James Kim was quoted on the Court of International Trade’s filing that amended their previous order to US Customs and Border Protection (CBP) to ignore tariffs installed under the International Emergency Economic Powers Act when processing refunds for unprocessed or unfinalized entries.
Forget science fiction — the race to wire computers directly into the human brain is well underway, and it is moving fast.
In 2025 alone there were over 1,000 lawsuits filed alleging violations of the California Invasion of Privacy Act (CIPA). Plaintiffs typically allege that third-party cookies, pixels, or other tracking mechanisms violate various aspects of CIPA as either wiretapping or trap and trace devices.
On March 9, a federal court in Connecticut issued a decision in Abira Medical Laboratories LLC v. Aetna Inc. et al. that underscores the continuing importance of clear and comprehensive assignment-of-benefits language in payer disputes.